National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting, 46001 [2021-17559]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 156 / Tuesday, August 17, 2021 / Notices
professional organizations; federal
agencies; and other stakeholders,
including interested members of the
public. Organizations are strongly
encouraged to submit a single response
that reflects the views of their
organization and their membership as a
whole.
DATES: Comments must be received by
11:59:59 p.m. (ET) on August 31, 2021
to ensure consideration.
ADDRESSES: All comments must be
submitted electronically on the
submission website, available at https://
rfi.grants.nih.gov/?s=60fef9beab
43000053007ed2.
khammond on DSKJM1Z7X2PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Please direct all inquiries to: Lisa
Gansheroff, NIDDKstrategicplan@
nih.gov, 301–496–6623.
SUPPLEMENTARY INFORMATION: This
Notice is in accordance with the 21st
Century Cures Act, NIH institutes are
required to regularly update their
strategic plans. The NIDDK’s ongoing
Institute-wide strategic planning process
will develop a broad vision for
accelerating research into the causes,
prevention, and treatment of diseases
and conditions within the Institute’s
mission. This overarching trans-NIDDK
Strategic Plan will complement
NIDDK’s disease-specific planning
efforts. The Strategic Plan will have a 5year time horizon but will also include
planning for longer term efforts that
could be initiated within this time
frame.
External input has been integral to the
strategic planning process. NIDDK
established a Working Group of Council,
comprised of 44 external scientists and
patient advocates, including a subset of
the members of NIDDK’s Advisory
Council and others with expertise across
the range of NIDDK’s mission areas. The
Institute also invited broad external
input with a public RFI in 2020, and
received valuable comments from
organizations, individual researchers,
people living with diseases in NIDDK’s
mission, and others. Based on input
from the Working Group, the previous
RFI, and Council, the Institute has
prepared a draft of the Strategic Plan;
the draft will be available for public
comment through August 31, 2021 via
the new RFI at the link above.
NIDDK is committed to empowering a
multidisciplinary research community;
engaging diverse stakeholders; and
leveraging discoveries of connections
among diseases across NIDDK’s mission
to improve prevention, treatment, and
health equity—pursuing pathways to
health for all. This theme is addressed
throughout the draft strategic plan.
VerDate Sep<11>2014
17:08 Aug 16, 2021
Jkt 253001
The draft Strategic Plan includes five
major sections:
• Advance understanding of
biological pathways and environmental
contributors to health and disease
• Advance pivotal clinical studies
and trials for prevention, treatment, and
cures in diverse populations
• Advance research to disseminate
and implement evidence-based
prevention strategies and treatments in
clinics and community settings, to
improve the health of all people, more
rapidly and more effectively
• Advance stakeholder engagement—
including patients and other
participants as true partners in research
• Promote efficient and effective ways
to serve as a trusted steward of public
resources and support research for
diseases across our mission
NIDDK invites comments on the draft
Strategic Plan from: The scientific
research community; patients and
caregivers; health care providers and
health advocacy organizations; scientific
and professional organizations; federal
agencies; and other stakeholders,
including interested members of the
public. Organizations are strongly
encouraged to submit a single response
that reflects the views of their
organization and membership as a
whole.
Responses to this RFI are voluntary
and may be submitted anonymously.
Please do not include any information
that you do not wish to make public.
Proprietary, classified, confidential, or
sensitive information should not be
included in your response. The
Government will use the information
submitted in response to this RFI at its
discretion. Individual feedback will not
be provided to any responder. The
Government reserves the right to use
any submitted information on public
websites, in reports, in summaries of the
state of the science, in any possible
resultant solicitation(s), grant(s), or
cooperative agreement(s), or in the
development of future funding
opportunity announcements. This RFI is
for informational and planning purposes
only and is not a solicitation for
applications or an obligation on the part
of the Government to provide support
for any ideas identified in response to
it. Please note that the Government will
not pay for the preparation of any
information submitted or for use of that
information. NIDDK looks forward to
your input and we hope that you will
share this RFI with your colleagues.
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
46001
Dated: August 11, 2021.
Bruce Tibor Roberts,
Health Science Policy Analyst, Office of
Scientific Program and Policy Analysis,
National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes of
Health.
[FR Doc. 2021–17535 Filed 8–16–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Clinical Trials and
Comparative Effectiveness Studies.
Date: August 23, 2021.
Time: 10:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH, NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892,
(301) 435–6033, rajarams@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: August 11, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–17559 Filed 8–16–21; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\17AUN1.SGM
17AUN1
]]>Agencies
[Federal Register Volume 86, Number 156 (Tuesday, August 17, 2021)]
[Notices]
[Page 46001]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17559]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; Clinical Trials and Comparative
Effectiveness Studies.
Date: August 23, 2021.
Time: 10:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Shanta Rajaram, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, NINDS/NIH, NSC, 6001 Executive Blvd., Suite 3208, MSC
9529, Bethesda, MD 20892, (301) 435-6033, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: August 11, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-17559 Filed 8-16-21; 8:45 am]
BILLING CODE 4140-01-P
